Skip to main content

Market Overview

Mid-Afternoon Market Update: Coherus Biosciences Drops After FDA Response Letter; TrovaGene Shares Surge


Toward the end of trading Monday, the Dow traded down 0.34 percent to 21,199.80 while the NASDAQ declined 0.93 percent to 6,150.45. The S&P also fell, dropping 0.38 percent to 2,422.55.

Leading and Lagging Sectors

Telecommunications services sector was the top gainer in the US market on Monday. Top gainers in the sector included Cincinnati Bell Inc. (NYSE: CBB), B Communications Ltd (NASDAQ: BCOM), and Telephone & Data Systems, Inc. (NYSE: TDS).

In trading on Monday, technology shares fell 1.36 percent. Meanwhile, top losers in the sector included Kopin Corporation (NASDAQ: KOPN), down 7 percent, and GSI Technology, Inc. (NASDAQ: GSIT), down 7 percent.

Top Headline

General Electric Company (NYSE: GE) announced the retirement of its CEO Jeff Immelt.

After 30 years with General Electric Company, GE Healthcare Limited CEO and President John Flannery is about to inherit all of corporate leadership.

Effective Aug. 1, Flannery, 55, will succeed retiring CEO Jeffrey Immelt, who will retain his role as chairman through the end of the year before relinquishing it to Flannery.

Equities Trading UP

GTx, Inc. (NASDAQ: GTXI) shares shot up 78 percent to $5.49 after the company disclosed positive preliminary results from ongoing Phase 2 proof-of-concept clinical trial in women with stress urinary incontinence.

Shares of XBiotech Inc (NASDAQ: XBIT) got a boost, shooting up 38 percent to $4.41 after falling 66.03 percent on Friday.

TrovaGene Inc (NASDAQ: TROV) shares were also up, gaining 27 percent to $1.02 after the company reported a deal with AstraZeneca for utilization of Trovera ctDNA test and services in prospective biomarker study.

Equities Trading DOWN

Coherus Biosciences Inc (NASDAQ: CHRS) shares dropped 28 percent to $14.82 after the company disclosed that it has received a Complete Response Letter from the FDA for its application for its CHS-1701. In the letter, the FDA has requested additional information in which the company has pledged to provide.

Shares of Pandora Media Inc (NYSE: P) were down 5 percent to $8.13. Oppenheimer downgraded Pandora from Outperform to Perform.

Volt Information Sciences, Inc. (NYSE: VISI) was down, falling around 20 percent to $4.10. On Friday, Volt Information Sciences reported a Q2 loss of $854,000 on revenue of $303 million.


In commodity news, oil traded up 0.92 percent to $46.25 while gold traded down 0.22 percent to $1,268.60.

Silver traded down 1.67 percent Monday to $16.935, while copper fell 1.28 percent to $2.6155.


European shares closed lower today. The eurozone’s STOXX 600 fell 0.97 percent, the Spanish Ibex Index dropped 1.24 percent, while Italy’s FTSE MIB Index slipped 1 percent. Meanwhile the German DAX declined 0.98 percent, and the French CAC 40 slipped 1.12 percent while U.K. shares fell 0.21 percent.


The U.S. budget deficit increased to $88.4 billion in May, compared to $53 billion in the year-ago period, the Treasury Department reported.


Related Articles (CBB + BCOM)

View Comments and Join the Discussion!

Posted-In: Mid-Afternoon Market UpdateNews Eurozone Commodities Global Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at